Postpartum low-dose esketamine aids moms with prenatal depression
A single low dose of esketamine after childbirth reduces depressive episodes at 42 days postpartum among mothers with prenatal depression, according to a study published online April 10 in The BMJ.
Facebook Comments
https://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.png00aajahttps://www.sarkaridoctor.com/wp-content/uploads/2022/01/logo@2xx.pngaaja2024-04-21 12:06:002024-04-21 12:06:00Postpartum low-dose esketamine aids moms with prenatal depression
